EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment

Zahra Abousalman-Rezvani iD, Ahmed Refaat iD, Pouya Dehghankelishadi iD, Hossein Roghani-Mamaqani iD, Lars Esser iD, Nicolas H Voelcker iD

Advanced Healthcare Materials · 2024-05 · 13 (12)

DOI: 10.1002/adhm.202302902 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.03.2024. Verfasst von Zahra Abousalman-Rezvani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, VIC 3052, Austr…. Hauptthemen laut MEDLINE: Brain Neoplasms, Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Melbourne Centre for Nanofabrication, Australian National Fabrication Facility, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain cancers, especially glioblastoma multiforme, are associated with poor prognosis due to the limited efficacy of current therapies. Nanomedicine has emerged as a versatile technology to treat various diseases, including cancers, and has played an indispensable role in combatting the COVID‐19 pandemic as evidenced by the role that lipid nanocarrier‐based vaccines have played. The tunability of nanocarrier physicochemical properties —including size, shape, surface chemistry, and drug release kinetics— has resulted in the development of a wide range of nanocarriers for brain cancer treatment. These nanocarriers can improve the pharmacokinetics of drugs, increase blood‐brain barrier transfer efficiency, and specifically target brain cancer cells. These unique features would potentially allow for more efficient treatment of brain cancer with fewer side effects and better therapeutic outcomes. This review provides an overview of brain cancers, current therapeutic options, and challenges to efficient brain cancer treatment. The latest advances in nanomedicine strategies are investigated with an emphasis on targeted and stimulus‐responsive nanocarriers and their potential for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsDrug CarriersNanoparticlesHumansNanomedicineBlood-Brain BarrierCOVID-19AnimalsDrug Delivery SystemsSARS-CoV-2Antineoplastic Agents

Stichwörter der Autor:innen

brain cancer therapyglioblastomananomedicinestimuli‐responsive nanoparticlestargeted drug delivery

Substanzen

Drug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Melbourne, VIC 3052, Australia.
  • Biomedical Manufacturing, Commonwealth Scientific and Industrial Research Organization, Research Way, Melbourne, VIC 3168, Australia.
  • Pharmaceutics Department, Faculty of Pharmacy - Alexandria University, 1 El-Khartoum Square, Alexandria, 21021, Egypt.
  • Faculty of Polymer Engineering, Sahand University of Technology, Tabriz, P.O. Box: 51335/1996, Iran.
  • Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, 151 Wellington Rd, Melbourne, VIC 3168, Australia.
  • Department of Materials Science & Engineering, Faculty of Engineering, Monash University, 14 Alliance Ln, Melbourne, VIC 3168, Australia.

ORCID-Profile: Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas H Voelcker

Förderung

  • Melbourne Centre for Nanofabrication
  • Australian National Fabrication Facility
  • Australian Research Council
  • Monash Graduate Scholarship
  • CASS Foundation
  • Tour de Cure

Zitieren

APA

Abousalman-Rezvani, Z., Refaat, A., Dehghankelishadi, P., Roghani-Mamaqani, H., Esser, L., & Voelcker, N. H. (2024). Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment. Advanced Healthcare Materials, 13(12). https://doi.org/10.1002/adhm.202302902

Vancouver

Abousalman-Rezvani Z, Refaat A, Dehghankelishadi P, Roghani-Mamaqani H, Esser L, Voelcker NH. Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment. Advanced Healthcare Materials. 2024;13(12). doi:10.1002/adhm.202302902

BibTeX
@article{AbousalmanRezvani2024,
  author = {Abousalman-Rezvani, Zahra and Refaat, Ahmed and Dehghankelishadi, Pouya and Roghani-Mamaqani, Hossein and Esser, Lars and Voelcker, Nicolas H},
  title = {Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {12},
  doi = {10.1002/adhm.202302902}
}
Kostenlos starten →